Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)
The Lancet Oncology, January 2024
Nephron Sparing Treatment (NEST) for small renal masses: A feasibility cohort-embedded randomised controlled trial comparing percutaneous cryoablation and robot-assisted partial nephrectomy
Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis
Preoperative renal parenchyma volume as a predictor of kidney function following nephrectomy of complex renal masses
Patient-reported outcome measurement and reporting for patients with advanced renal cell carcinoma: A systematic literature review
Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time
Oncological outcomes of delayed nephrectomy after optimal response to immune checkpoint inhibitors for metastatic renal cell carcinoma
European Urology Oncology, October 2022
Oncological outcomes of delayed nephrectomy after optimal response to immune checkpoint inhibitors for metastatic renal cell carcinoma
Local treatment of recurrent renal cell carcinoma may have a significant survival effect across all risk-of-recurrence groups
European Urology Open Science, January 2023
Local treatment of recurrent renal cell carcinoma may have a significant survival effect across all risk-of-recurrence groups
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More